MeiraGTx Holdings plc (MGTX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MGTX SEC filings page.
MeiraGTx Holdings plc (MGTX) reported $397.5M in revenue over the twelve months to Jun 30, 2026, up 948.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovery is narrowing cash consumption, but heavy R&D spending has pushed the balance sheet into negative equity.
The 2025 revenue rebound coincided with operating cash outflow narrowing from$104M in FY2024 to$46M , indicating better cash conversion even though operations remained cash-consuming. Yet the earnings-to-cash gap persisted: net loss was$114M against operating cash outflow of$46M , so accounting losses still exceeded immediate cash use.
R&D reached
The balance sheet crossed an important structural threshold: liabilities exceeded assets in FY2025, producing negative equity of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of MeiraGTx Holdings plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
MeiraGTx Holdings plc held $72.7M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $46.4M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and MeiraGTx Holdings plc scores 44/100 among other emerging companies.
MeiraGTx Holdings plc had 81M shares outstanding at the end of fiscal year 2025, against 79M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and MeiraGTx Holdings plc scores 44/100 among other emerging companies.
MeiraGTx Holdings plc spent $129.6M on research and development in fiscal year 2025, which was 69.2% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and MeiraGTx Holdings plc scores 90/100 among other emerging companies.
MeiraGTx Holdings plc reported revenue of $81.4M in fiscal year 2025, against $33.3M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and MeiraGTx Holdings plc scores 88/100 among other emerging companies.
MeiraGTx Holdings plc's operations used $46.4M of cash in fiscal year 2025, against $104.5M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and MeiraGTx Holdings plc scores 73/100 among other emerging companies.
MeiraGTx Holdings plc's cash, cash equivalents and investments came to $72.7M at the end of fiscal year 2025, against $250.2M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and MeiraGTx Holdings plc scores 32/100 among other emerging companies.
MeiraGTx Holdings plc scores -2.96, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.2B) relative to total liabilities ($250.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
MeiraGTx Holdings plc passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
MeiraGTx Holdings plc reported a net loss of $114.2M while operations used $46.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.
MeiraGTx Holdings plc reported an operating loss of $106.0M against $12.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
MeiraGTx Holdings plc generated $321.4M in revenue in Q2 2026. This represents an increase of 8608.6% from the same quarter a year earlier. Against the prior quarter it is up 109604.4%.
MeiraGTx Holdings plc's EBITDA was $247.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 694.3% from the same quarter a year earlier. Against the prior quarter it is up 753.9%.
MeiraGTx Holdings plc reported $160.7M in net income in Q2 2026. This represents an increase of 514.3% from the same quarter a year earlier. Against the prior quarter it is up 447.0%.
MeiraGTx Holdings plc earned $1.71 per diluted share (EPS) in Q2 2026. This represents an increase of 456.3% from the same quarter a year earlier. Against the prior quarter it is up 400.0%.
Cash & Balance Sheet
MeiraGTx Holdings plc recorded an outflow of $38.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 14.0% from the same quarter a year earlier. Against the prior quarter it is down 346.0%.
MeiraGTx Holdings plc held $143.2M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
MeiraGTx Holdings plc's operating margin was 76.0% in Q2 2026, reflecting core business profitability. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
MeiraGTx Holdings plc's net profit margin was 50.0% in Q2 2026, showing the share of revenue converted to profit. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
MeiraGTx Holdings plc's ROE was 74.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1385.1 percentage points from the same quarter a year earlier.
Not reported for Q2 2026.
Capital Allocation
MeiraGTx Holdings plc invested $57.8M in research and development in Q2 2026. This represents an increase of 72.7% from the same quarter a year earlier. Against the prior quarter it is up 80.8%.
MeiraGTx Holdings plc repurchased no shares in Q2 2026. Against the prior quarter it is down 100.0%.
MeiraGTx Holdings plc invested $332K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 73.1% from the same quarter a year earlier. Against the prior quarter it is down 83.5%.
MGTX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321.4M+8608.6% | $293K-84.8% | $75.4M+252.3% | $410K-96.2% | $3.7M+1208.9% | $1.9M+176.3% | $21.4M+948.5% | $10.9M+113.8% |
| R&D Expenses | $57.8M+72.7% | $32.0M-2.4% | $30.8M+28.5% | $32.5M+24.0% | $33.5M-4.1% | $32.8M-4.5% | $24.0M-28.8% | $26.2M-5.8% |
| SG&A Expenses | $12.0M-2.4% | $8.9M-4.7% | $17.6M+3.0% | $13.6M+7.0% | $12.3M+9.4% | $9.4M-28.8% | $17.1M+41.0% | $12.7M+27.1% |
| Operating Income | $244.4M+645.7% | -$40.8M+1.9% | $26.5M+184.1% | -$46.1M-15.0% | -$44.8M+2.4% | -$41.6M+11.1% | -$31.5M+28.0% | -$40.0M-22.2% |
| EBITDA | $247.2M+694.3% | -$37.8M+1.8% | $29.6M+204.1% | -$42.9M-16.6% | -$41.6M+2.5% | -$38.5M+11.5% | -$28.4M+28.7% | -$36.8M-25.6% |
| Interest Expense | $3.5M+15.7% | $2.8M-6.4% | $3.1M-10.4% | $3.1M-8.7% | $3.0M-6.8% | $3.0M-6.4% | $3.4M-1.1% | $3.4M-0.7% |
| Income Tax | $2.4M | $0 | N/A | N/A | N/A | $0 | $0 | $0 |
| Net Income | $160.7M+514.3% | -$46.3M-15.8% | $15.1M+138.3% | -$50.5M-28.4% | -$38.8M+20.2% | -$40.0M-95.6% | -$39.4M-294.9% | -$39.3M+11.2% |
| EPS (Basic) | $1.76+466.7% | -$0.57-11.8% | $0.19+138.0% | -$0.62-12.7% | -$0.48+36.8% | -$0.51-59.4% | -$0.50-219.0% | -$0.55+25.7% |
| EPS (Diluted) | $1.71+456.3% | -$0.57-11.8% | $0.19+138.0% | -$0.62-12.7% | -$0.48+36.8% | -$0.51-59.4% | -$0.50 | -$0.55+25.7% |
| Diluted Shares (Avg) | 94M+16.4% | 81M+2.9% | N/A | 81M+13.0% | 81M+25.2% | 79M+23.4% | N/A | 72M+20.3% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.
MGTX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $396.4M+99.5% | $244.7M+9.2% | $244.4M-9.4% | $189.5M-36.7% | $198.7M-25.5% | $224.0M-27.6% | $269.8M-17.4% | $299.5M+12.1% |
| Current Assets | $218.3M+363.7% | $96.2M+20.4% | $91.8M-25.7% | $34.2M-75.4% | $47.1M-57.5% | $79.9M-46.5% | $123.5M-22.6% | $139.0M+34.3% |
| Cash & Equivalents | $143.2M+345.1% | $71.5M+7.5% | $65.9M-36.4% | $14.8M-87.9% | $32.2M-67.8% | $66.5M-44.2% | $103.7M-20.0% | $122.9M+93.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | N/A | N/A | N/A | N/A | $314K | $607K | $385K | N/A |
| Accounts Receivable | N/A | $3.3M+344.6% | $3.0M+324.3% | $2.8M-14.4% | $2.3M+42.4% | $734K-93.3% | $707K-93.0% | $3.3M-85.4% |
| Long-Term Investments | $39.8M | $0 | $6.7M | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $180.7M-7.7% | $302.8M+58.6% | $250.2M+23.9% | $230.0M+12.9% | $195.8M+4.9% | $190.9M+1.8% | $201.9M+7.1% | $203.8M+16.2% |
| Current Liabilities | $58.1M+8.7% | $176.1M+236.3% | $122.6M+101.6% | $152.9M+157.4% | $53.4M+13.7% | $52.4M+10.2% | $60.8M-9.4% | $59.4M-6.4% |
| Non-Current Liabilities | $122.6M-13.9% | $126.7M-8.6% | $127.7M-9.5% | $77.1M-46.6% | $142.3M+1.9% | $138.5M-1.0% | $141.1M+16.2% | $144.3M+29.1% |
| Total Equity | $215.8M+7189.9% | -$58.1M-275.6% | -$5.8M-108.5% | -$40.6M-142.4% | $3.0M-96.3% | $33.1M-72.8% | $67.8M-50.9% | $95.7M+4.2% |
| Retained Earnings | -$701.8M+10.1% | -$862.5M-16.2% | -$816.2M-16.3% | -$831.3M-25.5% | -$780.8M-25.3% | -$742.0M-29.1% | -$702.0M-26.7% | -$662.6M-15.3% |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
MGTX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$38.5M+12.3% | $17.8M+148.4% | $46.6M+300.3% | -$12.2M+51.2% | -$43.9M-125.9% | -$36.8M-0.2% | -$23.3M-60.0% | -$25.0M-2.5% |
| Depreciation & Amortization | $2.8M-11.5% | $3.0M-2.4% | $3.1M+1.4% | $3.2M-3.2% | $3.2M-0.9% | $3.1M-5.9% | $3.1M-21.5% | $3.3M-6.3% |
| Stock-Based Compensation | $3.8M-33.2% | $3.7M-25.2% | N/A | $6.0M-5.6% | $5.7M-2.5% | $4.9M-29.8% | N/A | $6.3M-10.6% |
| Capital Expenditures | $332K-73.1% | $2.0M+17.4% | $272K-77.7% | $610K-16.4% | $1.2M-7.1% | $1.7M+1.9% | $1.2M-59.8% | $730K-79.5% |
| Free Cash Flow | -$38.9M+14.0% | $15.8M+141.0% | $46.4M+289.3% | -$12.8M+50.2% | -$45.2M-117.4% | -$38.5M-0.3% | -$24.5M-39.4% | -$25.8M+8.0% |
| Investing Cash Flow | -$23.6M-3005.9% | -$2.3M-32.0% | -$1.1M+10.6% | -$547K+58.4% | -$761K+42.7% | -$1.7M-106.3% | -$1.2M-102.4% | -$1.3M+63.1% |
| Financing Cash Flow | $133.9M+2356.8% | -$10.1M-690.4% | $5.3M+25.5% | -$219K-100.4% | $5.5M+240.0% | $1.7M+234.9% | $4.2M-84.7% | $50.0M+12465.6% |
| Share Buybacks | $0 | $18.2M | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
MGTX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 76.0% | -13930.7% | 35.1% | -11232.0% | -1213.6% | -2159.7% | -147.2% | -367.0% |
| Net Margin | 50.0% | -15806.5% | 20.0% | -12320.2% | -1051.1% | -2075.9% | -184.2% | -360.5% |
| Return on Equity | 74.5%+1385.1pp | N/A | N/A | N/A | -1310.6%-1249.9pp | -120.8%-104.0pp | -58.1%-72.7pp | -41.1%+7.1pp |
| Return on Assets | 40.5%+60.1pp | -18.9%-1.1pp | 6.2%+20.8pp | -26.7%-13.5pp | -19.5%-1.3pp | -17.8%-11.2pp | -14.6%-20.8pp | -13.1%+3.5pp |
| Current Ratio | 3.76+2.9x | 0.55-1.0x | 0.75-1.3x | 0.22-2.1x | 0.88-1.5x | 1.53-1.6x | 2.03-0.3x | 2.34+0.7x |
| Debt-to-Equity | 0.84-65.3x | N/A | N/A | N/A | 66.13+63.8x | 5.77+4.2x | 2.98+1.6x | 2.13+0.2x |
| Asset Turnover | 0.81+0.8x | 0.000.0x | 0.31+0.2x | 0.000.0x | 0.020.0x | 0.010.0x | 0.08+0.1x | 0.040.0x |
| FCF Margin | -12.1% | 5393.2% | 61.5% | -3128.1% | -1224.1% | -2000.9% | -114.5% | -236.0% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$5.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.75), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| MeiraGTx Holdings plc MGTX | FY2025 | $81.4M | -$114.2M | N/A | $1.2B | 62/100 |
| Keros Therapeutics, Inc. KROS | FY2025 | $243.9M | $87.0M | 35.7% | $219.7M | 91/100 |
| Savara Inc. SVRA | FY2025 | N/A | -$118.8M | N/A | $1.1B | — |
| Oruka Therapeutics, Inc. ORKA | FY2025 | N/A | -$105.4M | N/A | $6.1B | — |
| Nurix Therapeutics, Inc. NRIX | FY2025 | $84.0M | -$264.5M | N/A | $2.6B | 53/100 |
| Rigel Pharmaceuticals Inc. (New) RIGL | FY2025 | $294.3M | $367.0M | N/A | $882.4M | 62/100 |
Where MeiraGTx Holdings plc Ranks
Frequently Asked Questions
What is MeiraGTx Holdings plc's annual revenue?
MeiraGTx Holdings plc (MGTX) reported $81.4M in total revenue for fiscal year 2025. This represents a 144.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is MeiraGTx Holdings plc's revenue growing?
MeiraGTx Holdings plc (MGTX) revenue grew by 144.6% year-over-year, from $33.3M to $81.4M in fiscal year 2025.
Is MeiraGTx Holdings plc profitable?
No, MeiraGTx Holdings plc (MGTX) reported a net income of -$114.2M in fiscal year 2025.
What is MeiraGTx Holdings plc's EBITDA?
MeiraGTx Holdings plc (MGTX) had EBITDA of -$93.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is MeiraGTx Holdings plc's free cash flow?
MeiraGTx Holdings plc (MGTX) recorded an outflow of $50.2M in free cash flow during fiscal year 2025. This represents a 54.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is MeiraGTx Holdings plc's operating cash flow?
MeiraGTx Holdings plc (MGTX) recorded an outflow of $46.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are MeiraGTx Holdings plc's total assets?
MeiraGTx Holdings plc (MGTX) had $244.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are MeiraGTx Holdings plc's capital expenditures?
MeiraGTx Holdings plc (MGTX) invested $3.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does MeiraGTx Holdings plc spend on research and development?
MeiraGTx Holdings plc (MGTX) invested $129.6M in research and development during fiscal year 2025.
What is MeiraGTx Holdings plc's current ratio?
MeiraGTx Holdings plc (MGTX) had a current ratio of 0.75 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is MeiraGTx Holdings plc's return on assets (ROA)?
MeiraGTx Holdings plc (MGTX) had a return on assets of -46.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is MeiraGTx Holdings plc's P/E ratio?
MeiraGTx Holdings plc (MGTX) trades at 15.7x earnings, its market capitalization divided by net income of $79.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.2B as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is MeiraGTx Holdings plc's price-to-sales ratio?
MeiraGTx Holdings plc (MGTX) trades at 3.1x sales, its market capitalization divided by revenue of $397.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.2B as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does MeiraGTx Holdings plc's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, MeiraGTx Holdings plc (MGTX) held $72.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $46.4M over that year. Dividing the one by the other, the reported balance equals about 19 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is MeiraGTx Holdings plc's debt-to-equity ratio negative or not reported?
MeiraGTx Holdings plc (MGTX) has negative shareholder equity of -$5.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is MeiraGTx Holdings plc's Altman Z-Score?
MeiraGTx Holdings plc (MGTX) has an Altman Z-Score of -2.96, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is MeiraGTx Holdings plc's Piotroski F-Score?
MeiraGTx Holdings plc (MGTX) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are MeiraGTx Holdings plc's earnings high quality?
MeiraGTx Holdings plc (MGTX) reported a net loss of $114.2M while operations used $46.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can MeiraGTx Holdings plc cover its interest payments?
MeiraGTx Holdings plc (MGTX) reported an operating loss of $106.0M against $12.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is MeiraGTx Holdings plc?
MeiraGTx Holdings plc (MGTX) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.